PubMed COVID-19 Clinical Care
25221 - 25230 of 44979 results found
Experimental Drugs in Randomized Controlled Trials for Long-COVID: What's in the Pipeline? A Systematic and Critical Review
Description
INTRODUCTION: Over three years have passed since the emergence of coronavirus disease 2019 (COVID-19), and yet the treatment for long-COVID, a post-COVID-19 syndrome, remains long overdue. Currently, there is no standardized treatment available for
Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328)
Description
CONCLUSION: Vaccine-induced SARS-CoV-2 neutralization capacity was similar between PLWH vs HIV-negative persons without past COVID-19 infection, demonstrating favourable humoral-mediated immunogenicity. Both HIV+ and HIV-negative persons demonstrated
Early Treatment of Multisystem Inflammatory Syndrome in Children
Description
CONCLUSIONS: Glucocorticoids and intravenous immunoglobulin were independently associated with shorter hospital length of stay when given early in hospitalization to MIS-C patients after accounting for potential confounding factors. The optimal dose
Emotional problems in young children during the SARS-CoV-2-pandemic and child attachment
Description
CONCLUSIONS: Our study shows that there is an association between attachment security and emotional problems and the impact of the SARS-CoV-2 pandemic on the mental health of preschool children in Germany. The emotional problems of all children
Hemophagocytic lymphohistiocytosis secondary to histoplasmosis: A case report in a patient with AIDS and recent SARS-CoV-2 infection and minireview
Description
Here, we describe the case of a naïve HIV late presenter female African patient with progressive disseminated histoplasmosis and a severe life-threatening clinical picture in a non-endemic area. She had not visited Africa in the past decade. She
Identification of cuproptosis-related molecular subtypes and a novel predictive model of COVID-19 based on machine learning
Description
CONCLUSION: Our study constructed and validated an cuproptosis-associated risk model and the risk score can be used as a powerful biomarker for predicting the existence of SARS-CoV-2 infection.
Institutionalization of Health System to Combat the COVID-19 Pandemic in Iran
Description
No abstract
